Securian Asset Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$469K Sell
5,142
-146
-3% -$12.8K 0.02% 668
2026
Q1
$478K Sell
5,288
-100
-2% -$9.18K 0.02% 626
2025
Q4
$484K Sell
5,388
-4,066
-43% -$386K 0.02% 617
2025
Q3
$931K Sell
9,454
-786
-8% -$77.9K 0.02% 457
2025
Q2
$934K Sell
10,240
-200
-2% -$19.3K 0.03% 453
2025
Q1
$1.18M Sell
10,440
-200
-2% -$21.4K 0.04% 368
2024
Q4
$1.12M Sell
10,640
-622
-6% -$66.7K 0.03% 391
2024
Q3
$1.22M Sell
11,262
-566
-5% -$61.8K 0.04% 372
2024
Q2
$1.28M Sell
11,828
-451
-4% -$53.2K 0.04% 353
2024
Q1
$1.62M Sell
12,279
-936
-7% -$117K 0.05% 310
2023
Q4
$1.61M Sell
13,215
-1,750
-12% -$195K 0.05% 309
2023
Q3
$1.68M Sell
14,965
-1,913
-11% -$243K 0.05% 305
2023
Q2
$2.46M Sell
16,878
-510
-3% -$69.3K 0.06% 276
2023
Q1
$2.25M Buy
17,388
+212
+1% +$26.6K 0.06% 288
2022
Q4
$2.19M Buy
17,176
+100
+0.6% +$11.6K 0.06% 289
2022
Q3
$1.78M Buy
17,076
+244
+1% +$26.8K 0.05% 308
2022
Q2
$1.77M Sell
16,832
-95
-0.6% -$11.3K 0.04% 370
2022
Q1
$2.17M Sell
16,927
-714
-4% -$86.1K 0.04% 380
2021
Q4
$2.18M Sell
17,641
-309
-2% -$40.4K 0.04% 389
2021
Q3
$2.55M Sell
17,950
-206
-1% -$30.3K 0.05% 329
2021
Q2
$2.83M Buy
18,156
+103
+0.6% +$16.7K 0.06% 311
2021
Q1
$2.81M Sell
18,053
-663
-4% -$103K 0.06% 300
2020
Q4
$2.8M Sell
18,716
-690
-4% -$97.5K 0.06% 290
2020
Q3
$2.56M Sell
19,406
-184
-0.9% -$24K 0.06% 279
2020
Q2
$2.27M Sell
19,590
-1,112
-5% -$128K 0.06% 300
2020
Q1
$2.03M Sell
20,702
-358
-2% -$46.9K 0.06% 294
2019
Q4
$3.06M Sell
21,060
-1,016
-5% -$140K 0.07% 276
2019
Q3
$2.94M Sell
22,076
-103
-0.5% -$13.3K 0.07% 281
2019
Q2
$2.54M Buy
22,179
+162
+0.7% +$19K 0.06% 311
2019
Q1
$2.73M Buy
22,017
+265
+1% +$30.1K 0.07% 279
2018
Q4
$2.19M Buy
21,752
+359
+2% +$40.4K 0.06% 296
2018
Q3
$2.73M Buy
21,393
+20
+0.1% +$2.38K 0.06% 276
2018
Q2
$2.31M Buy
21,373
+179
+0.8% +$19.5K 0.06% 306
2018
Q1
$2.24M Buy
21,194
+103
+0.5% +$12K 0.06% 314
2017
Q4
$2.47M Buy
21,091
+17
+0.1% +$1.92K 0.06% 302
2017
Q3
$2.4M Buy
21,074
+104
+0.5% +$12K 0.06% 299
2017
Q2
$2.61M Buy
20,970
+93
+0.4% +$11K 0.07% 273
2017
Q1
$2.48M Buy
20,877
+182
+0.9% +$20.6K 0.07% 287
2016
Q4
$2.07M Buy
20,695
+292
+1% +$31.3K 0.06% 319
2016
Q3
$2.58M Buy
20,403
+443
+2% +$54.7K 0.07% 262
2016
Q2
$2.33M Buy
19,960
+2,093
+12% +$237K 0.07% 277
2016
Q1
$1.85M Buy
17,867
+848
+5% +$82K 0.05% 326
2015
Q4
$1.7M Buy
17,019
+525
+3% +$51.4K 0.05% 335
2015
Q3
$1.5M Sell
16,494
-103
-0.6% -$10.3K 0.05% 332
2015
Q2
$1.76M Buy
16,597
+309
+2% +$34.2K 0.06% 320
2015
Q1
$1.86M Buy
16,288
+496
+3% +$56.6K 0.05% 322
2014
Q4
$1.74M Buy
15,792
+372
+2% +$39.2K 0.05% 321
2014
Q3
$1.5M Buy
15,420
+21
+0.1% +$2.07K 0.05% 331
2014
Q2
$1.55M Sell
15,399
-103
-0.7% -$10.1K 0.05% 316
2014
Q1
$1.42M Sell
15,502
-177
-1% -$16.3K 0.05% 325
2013
Q4
$1.42M Buy
15,679
+122
+0.8% +$10.6K 0.05% 337
2013
Q3
$1.24M Buy
15,557
+245
+2% +$19.3K 0.05% 358
2013
Q2
$1.11M Buy
+15,312
New +$1.14M 0.05% 364

Other funds holding ZBH

Securian Asset Management's ZBH Position: Q2 2026 in Review

Securian Asset Management reduced its Zimmer Biomet (ZBH) stake by 2.8% in Q2 2026, selling an estimated $12.8K and leaving 5,142 shares worth $469K. The position accounts for 0.02% of the portfolio, ranked #668.

Securian Asset Management first reported a position in ZBH in Q2 2013 and has held it in 53 quarters since. The position peaked at $3.06M in Q4 2019. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Securian Asset Management held 5,142 shares of Zimmer Biomet worth $469K as of Q2 2026.
  • Securian Asset Management sold 146 Zimmer Biomet shares in Q2 2026, an estimated $12.8K.
  • Zimmer Biomet made up 0.02% of Securian Asset Management's portfolio in Q2 2026, its #668 holding.
  • Securian Asset Management first reported a position in Zimmer Biomet in Q2 2013 and has held it in 53 quarters since.
  • Securian Asset Management's Zimmer Biomet position peaked at $3.06M in Q4 2019.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.